Petros Pharmaceuticals, Inc. (PTPI) NASDAQ

0.03

-0.0018(-5.88%)

Updated at August 18 03:46PM

Currency In USD

Valuation

Market Cap79.06M
Enterprise Value82.73M
P/E Ratio-0
PEG Ratio0
Price/Sales Ratio0.24
Price/Book Ratio-0
Enterprise/Revenue-0.21
Enterprise/EBITDA0.07

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-3.87
Operating Margin-4.09

Management Effectiveness

Return On Assets-0.82
Return On Equity12.14

Income Statement

Revenue5.11M
Revenue/Share3.2
Gross Profit3.9M
EBITDA-10.81M
Net Income-14.32M
Diluted EPS-0.02

Balance Sheet

Total Cash8.93M
Total Cash/Share7.69
Total Debt7.25M
Total Debt/Equity-0.76
Current Ratio0.67
Book Value Per Share-8.25

Price History

52-Week Change-99.68
52-Week High16.25
52-Week Low0.02
Moving Average 50 Days0.03
Moving Average 200 Days3.48

Statistics

Average Volume5.9M
Shares Outstanding31.16M
% Held by Institutions3.35

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.02
Last Split Factor1:25
Last Split DateMay 01, 2025